Sage Therapeutics Insider Trades

SAGE

Track insider trading activity from Sage Therapeutics executives and directors. See which insiders are buying and selling SAGE stock.

Trades Last 12 Months

All Insider Trades for Sage Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Quirk Michael C. See Remarks
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$564k 64,999 shares
$8.68
$8.68
Shiferman Gregory L. See Remarks
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$330k 38,000 shares
$8.68
$8.68
Greene Barry E President And CEO
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$407k 46,940 shares
$8.68
$8.68
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$26k 3,000 shares
$8.68
$8.68
Benecchi Christopher Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$699k 80,553 shares
$8.68
$8.68
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$305k 35,093 shares
$8.68
$8.68
Cola Michael F Director
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$187k 21,500 shares
$8.68
$8.68
Germano Geno J Director
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$187k 21,500 shares
$8.68
$8.68
Federer Jessica Director
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$187k 21,500 shares
$8.68
$8.68
Frates James M Director
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$353k 40,654 shares
$8.68
$8.68
Gault Laura Chief Medical Officer
Holding Value $301k 34,649 shares
Last Trade
Feb 13, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.92k 685 shares
$7.18
$8.68
Cook Anne Marie Svp, GC & Secretary
Holding Value $209k 24,040 shares
Last Trade
Aug 05, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$40.3k 4,503 shares
$8.96
$8.68
Iguchi Kimi CFO & Treasurer
Holding Value $738k 85,041 shares
Last Trade
Aug 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$121k 13,500 shares
$8.96
$8.68
Holding Value $109k 12,500 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$136k 12,500 shares
$10.90
$8.68
Jonas Jeffrey M Director
Holding Value $109k 12,500 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$136k 12,500 shares
$10.90
$8.68
Paul Steven M Director
Holding Value $34.5k 3,971 shares
Last Trade
Jan 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.1k 3,971 shares
$21.67
$8.68
Starr Kevin P Director
Holding Value $86.8k 10,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$561k 10,000 shares
$56.10
$8.68
Robichaud Albert Chief Scientific Officer
Holding Value $145k 16,720 shares
Last Trade
Feb 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$757k 16,720 shares
$45.28
$8.68
Kanes Stephen Chief Medical Officer
Holding Value $127k 14,591 shares
Last Trade
Oct 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$153k 3,800 shares
$40.29
$8.68
Cloonan Michael Chief Business Officer
Holding Value $165k 19,000 shares
Last Trade
Feb 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.56M 19,000 shares
$82.27
$8.68

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up